Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,120 Cr
down ₹58.5 Cr vs May 2022
- Stocks held
- 24
- unchanged
- Top 10 weight
- 70.5%
- of the portfolio in its ten largest
- Cash & debt
- 0.1%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 3, trimmed 21
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In June 2022 it disclosed 24 stocks worth ₹1,120 Cr, down ₹58.5 Cr from May 2022. Its largest positions were Sun Pharmaceutical Industries Limited (14.9%), Cipla Limited (9.7%), Max Healthcare Institute Limited (7.9%); the ten largest together made up 70.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 57.1% of its equity. Cash and debt stood at 0.1%. Compared with May 2022 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
7%
Holds more stocks than 7% of peers
Cash
1%
Holds more cash than 1% of peers
What these mean: concentration · cash
Holdings in June 2022
Download CSVEvery line the fund disclosed, with the change against May 2022. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 14.88% | up 0.03 pts | ₹167 Cr | down ₹8.3 Cr | Trimmed |
| Cipla Limited | 9.71% | down 0.48 pts | ₹109 Cr | down ₹11.4 Cr | Trimmed |
| Max Healthcare Institute Limited | 7.91% | up 0.12 pts | ₹88.5 Cr | down ₹3.2 Cr | Trimmed |
| Dr. Reddy's Laboratories Limited | 6.57% | up 0.36 pts | ₹73.6 Cr | up ₹40 L | Added |
| IPCA Laboratories Limited | 6.33% | up 0.28 pts | ₹70.9 Cr | down ₹40 L | Trimmed |
| Apollo Hospitals Enterprise Limited | 6.30% | down 0.17 pts | ₹70.6 Cr | down ₹5.7 Cr | Trimmed |
| Procter & Gamble Health Limited | 5.94% | up 0.19 pts | ₹66.5 Cr | down ₹1.2 Cr | Trimmed |
| Lupin Limited | 4.69% | up 0.18 pts | ₹52.5 Cr | down ₹66 L | Trimmed |
| Alkem Laboratories Limited | 4.50% | up 0.01 pts | ₹50.4 Cr | down ₹2.5 Cr | Trimmed |
| Indoco Remedies Limited | 3.68% | up 0.32 pts | ₹41.2 Cr | up ₹1.6 Cr | Added |
| Vijaya Diagnostic Centre Limited | 3.03% | down 0.11 pts | ₹34 Cr | down ₹3.1 Cr | Trimmed |
| Globus Medical Inc | 2.67% | down 0.25 pts | ₹30 Cr | down ₹4.5 Cr | Trimmed |
| Intuitive Surgical Inc | 2.67% | down 0.14 pts | ₹29.9 Cr | down ₹3.3 Cr | Trimmed |
| ICICI Lombard General Insurance Company Limited | 2.42% | down 0.18 pts | ₹27.1 Cr | down ₹3.5 Cr | Trimmed |
| Abbott Laboratories | 2.40% | down 0.02 pts | ₹26.9 Cr | down ₹1.7 Cr | Trimmed |
| Abiomed Inc | 2.36% | up 0.06 pts | ₹26.5 Cr | down ₹67 L | Trimmed |
| Syngene International Limited | 2.30% | up 0.04 pts | ₹25.8 Cr | down ₹82 L | Trimmed |
| Alembic Pharmaceuticals Limited | 1.76% | up 0.08 pts | ₹19.8 Cr | down ₹10 L | Trimmed |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 1.72% | up 0.12 pts | ₹19.2 Cr | up ₹39 L | Added |
| Aarti Drugs Limited | 1.69% | down <0.01 pts | ₹18.9 Cr | down ₹1 Cr | Trimmed |
| Unichem Laboratories Limited | 1.41% | down 0.03 pts | ₹15.8 Cr | down ₹1.2 Cr | Trimmed |
| MedPlus Health Services Limited | 1.32% | down 0.09 pts | ₹14.7 Cr | down ₹1.9 Cr | Trimmed |
| Kovai Medical Center and Hospital Limited | 1.29% | up 0.10 pts | ₹14.5 Cr | up ₹45 L | Added |
| Narayana Hrudayalaya Limited | 1.25% | down 0.27 pts | ₹14 Cr | down ₹4 Cr | Trimmed |
| Illumina Inc | 1.09% | down 0.25 pts | ₹12.2 Cr | down ₹3.6 Cr | Trimmed |
| Cash, TREPS & receivables | 0.13% | up 0.11 pts | ₹1.5 Cr | up ₹1.2 Cr | Added |
What changed, May 2022 to Jun 2022
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Indoco Remedies Limitedup ₹1.6 Cr (+0.32% pts)
- Kovai Medical Center and Hospital Limitedup ₹45 L (+0.10% pts)
- Dr. Reddy's Laboratories Limitedup ₹40 L (+0.36% pts)
Trimmed Biggest reductions
- Cipla Limiteddown ₹11.4 Cr (−0.48% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since May 2022, the weight rose most in Pharmaceuticals & Biotechnology (+0.8 pts) and Pharmaceuticals (+0.3 pts), and fell most in Healthcare Services (−0.4 pts) and Healthcare Equipment & Supplies (−0.4 pts).
- Pharmaceuticals & Biotechnology56.3% → 57.1%+0.8 pts
- Pharmaceuticals7.3% → 7.6%+0.3 pts
- Healthcare Services26.4% → 26.0%−0.4 pts
- Healthcare Equipment & Supplies5.8% → 5.4%−0.4 pts
- Insurance2.6% → 2.5%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jun 2019 | Jun 2021 | Dec 2021 | Mar 2022 | May 2022 | Jun 2022 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.0% | 62.2% | 52.7% | 54.7% | 56.3% | 57.1% |
| Healthcare Services | 16.2% | 22.2% | 29.8% | 27.8% | 26.4% | 26.0% |
| Pharmaceuticals | 11.7% | 6.8% | 7.3% | 7.0% | 7.3% | 7.6% |
| Healthcare Equipment & Supplies | — | 6.0% | 6.3% | 6.4% | 5.8% | 5.4% |
| Insurance | 2.1% | 2.8% | 2.4% | 2.5% | 2.6% | 2.5% |
| Retailing | — | — | 1.4% | 1.5% | 1.4% | 1.3% |
Allocation in Jun 2022change vs May 2022
- Pharmaceuticals & Biotechnology (9)57.1%▲ 0.8 pts
- Healthcare Services (8)26.0%▼ 0.4 pts
- Pharmaceuticals (3)7.6%▲ 0.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jun 2022
0.1%
▲ 0.1 pts vs May 2022
- Cash alone
- 0.1%
- cash and net receivables
- A year earlier
- 2.9%
- Jun 2021 · now ▼ 2.7 pts
- Last 12 months
- −0.3% – 3.7%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.